Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells
Doc Wire News,
This article was originally published here Stem Cell Res Ther. 2022 Mar 7;13(1):103.
This article was originally published here Stem Cell Res Ther. 2022 Mar 7;13(1):103.
This article was originally published here Stem Cell Res Ther. 2022 Mar 7;13(1):103.